Thu, March 1, 2012
Wed, February 29, 2012
Tue, February 28, 2012
[ Tue, Feb 28th 2012 ]: Market Wire
ICON Acquires PriceSpective
Mon, February 27, 2012
Sat, February 25, 2012
Fri, February 24, 2012
[ Fri, Feb 24th 2012 ]: Market Wire
BrainStorm Featured on CNBC
Thu, February 23, 2012
[ Thu, Feb 23rd 2012 ]: Market Wire
00 am ET
Wed, February 22, 2012
Tue, February 21, 2012
Mon, February 20, 2012
Sat, February 18, 2012
Fri, February 17, 2012

Amgen to Present at the Citi 2012 Global Healthcare Conference


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. -the-citi-2012-global-healthcare-conference.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

Amgen to Present at the Citi 2012 Global Healthcare Conference -- THOUSAND OAKS, Calif., Feb. 23, 2012 /PRNewswire/ --

Amgen to Present at the Citi 2012 Global Healthcare Conference

[ ]

THOUSAND OAKS, Calif., Feb. 23, 2012 /PRNewswire/ -- Amgen (NASDAQ: [ AMGN ]) will present at the Citi 2012 Global Healthcare Conference on Tuesday, Feb. 28, 2012, at the Waldorf Astoria in New York City, beginning at 4:30 p.m. Eastern Standard Time. Arvind Sood, vice president, Investor Relations will present.  Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, [ www.amgen.com ], under Investors.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit [ www.amgen.com ]. Follow us on [ www.twitter.com/amgen ].

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo:  [ http://photos.prnewswire.com/prnh/20081015/AMGENLOGO ])

SOURCE Amgen

[ Back to top ]

RELATED LINKS
[ http://www.amgen.com ]


Publication Contributing Sources